Abbott Laboratories (ABT) — closed signal from October 28, 2025
Partial Published before the outcome was known, scored automatically when the window closed on January 26, 2026.
Predicted vs. what happened
What happened
Reached 32% of the predicted growth at its peak, without hitting the target.
The thesis — published October 28, 2025
Abbott looks like a steady, lower-risk stock that has fallen more than usual, which could offer a short-term opportunity. A major bank kept a $157 target, while another view says shares may be expensive, so balance optimism with care. Strong cash coming in and long-running dividends may help the price drift up over the next 3 months. Trend signs are still weak, so consider starting near the low end and add only if buyer interest improves.
Primary drivers
- The stock has dropped more than usual, yet the business is steady and resilient
- A major bank shows confidence and sets a $157 price goal, lifting sentiment
- Strong free cash and dependable dividends help support the share price
- Some think shares are pricey, so move carefully and keep positions modest
How it played out
ABT: the 12% target was not reached
Lyra published ABT on 2025-10-28 at $127.21 with an expected 12% short-term rise to $142.48. The thesis pointed to a steady business after a larger-than-usual drop, a major bank's $157 price goal, strong free cash, dependable dividends, and some caution that the shares may already be pricey.
Inside the window, ABT rose to $132.03 on 2025-11-18, a 3.8% peak gain. It stayed below the $142.48 target and never reached it. By 2026-01-26, the stock ended at $108.77. The thesis only partially played out: there was an early rise, but the target missed and the signal ended lower.
What happened during the window
On 2025-11-20, Abbott announced an agreement to acquire Exact Sciences. On 2026-01-22, Abbott reported fourth-quarter and full-year 2025 results and issued its 2026 financial outlook.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.